November 14th(Fri) - 15th(Sat), 2025
Grand InterContinental Seoul Parnas, Korea
*Alphabetical order by last name
Broad Institute of MIT & Harvard
Symposium 5
Speaker
November 14 (Fri), 14:50-16:10
Room A
AHA PREVENT Equations and Cardiovascular Disease Risk in Diverse Healthcare Populations
Keio University
Symposium 5
Speaker
November 14 (Fri), 14:50-16:10
Room A
Future Directions for ASCVD Risk Prediction in Japan: Triglycerides and HDL-C as Key Components of Residual Risk
Carol Davila University
Symposium 11
Panel
November 15 (Sat), 13:50-15:10
Room A
Keio University
Plenary Lecture 3
Speaker
November 15 (Sat), 10:10-10:50
Room A
History and Current Strategies to Prevent Cardiovascular Disease in Japan
University of Lisbon
Symposium 5
Panel
November 14 (Fri), 14:50-16:10
Room A
University of Toronto
Plenary Lecture 2
Speaker
November 14 (Fri), 13:50-14:30
Room A
SGLT2 Inhibitors and Cardiovascular Protection: What Are the Mechanistic Underpinnings?
Symposium 11
Speaker
November 15 (Sat), 13:50-15:10
Room A
Cross-Cutting Pharmacotherapy for CKM Syndrome
Kyoto University Graduate School of Medicine
Plenary Lecture 4
Speaker
November 15 (Sat), 12:50-13:30
Room A
Incretin-Based Therapies for Optimizing Type 2 Diabetes Management in Asia
Symposium 9
Speaker
November 15 (Sat), 10:50-12:10
Room A
GLP-1 Receptor Agonists in Cardiovascular Outcomes: From Glycemic Control to Protection
University of Washington
Plenary Lecture 1
Speaker
November 14 (Fri), 10:50-11:30
Room A
Translating the 2025 ACC/AHA Blood Pressure Guidelines into Practice
Symposium 5
Speaker
November 14 (Fri), 14:50-16:10
Room A
Cardiovascular Risk Prediction Models: Implications for East Asians